
Results
12
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
12 companies
Eli Lilly
Market Cap: US$1.0t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,115.68
7D
-8.6%
1Y
45.7%
Bruker
Market Cap: US$9.8b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
BRKR
US$50.30
7D
-20.0%
1Y
56.8%
Krystal Biotech
Market Cap: US$9.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$324.77
7D
-10.8%
1Y
136.5%
TG Therapeutics
Market Cap: US$6.9b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$48.74
7D
-8.9%
1Y
75.9%
Indivior Pharmaceuticals
Market Cap: US$4.4b
Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
US$36.50
7D
-11.0%
1Y
67.4%
Veracyte
Market Cap: US$3.6b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$46.41
7D
-16.6%
1Y
85.6%
Arcutis Biotherapeutics
Market Cap: US$3.2b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.03
7D
-8.4%
1Y
69.9%
Vera Therapeutics
Market Cap: US$2.3b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
VERA
US$29.95
7D
-10.1%
1Y
45.1%
Fortrea Holdings
Market Cap: US$1.8b
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE
US$17.99
7D
-13.1%
1Y
174.2%
Fortress Biotech
Market Cap: US$91.7m
Operates as a biopharmaceutical company in the United States and internationally.
FBIO
US$2.72
7D
-19.8%
1Y
42.8%
Polyrizon
Market Cap: US$19.0m
A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
PLRZ
US$10.20
7D
-12.8%
1Y
47.8%
International Stem Cell
Market Cap: US$2.1m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.25
7D
-13.1%
1Y
99.8%